CYP3A4 is a vitamin D-24- and 25-hydroxylase: Analysis of structure function by site-directed mutagenesis

被引:76
作者
Gupta, RP
He, YA
Patrick, KS
Halpert, JR
Bell, NH
机构
[1] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA
[3] Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
关键词
D O I
10.1210/jc.2004-0966
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies were performed to identify the microsomal enzyme that 24-hydroxylates vitamin D, whether 25-hydroxylation occurs, and structure function of the enzyme. Sixteen hepatic recombinant microsomal cytochrome P450 enzymes expressed in baculovirus-infected insect cells were screened for 24-hydroxylase activity. CYP3A4, a vitamin D-25-hydroxylase, and CYP1A1 had the highest 24-hydroxylase activity with 1alpha-hydroxyvitamin D-2 (1alphaOHD(2)) as substrate. The ratio of rates of 24-hydroxylation of 1alpha-hydroxyvitamin D-3 (1alphaOHD(3)), 1alphaOHD(2), and vitamin D-2 by CYP3A4 was 3.6/2.8/1.0. Structures of 24-hydroxyvitamin D-2, 1,24(S)-dihydroxyvitamin D-2, and 1,24-dihydroxyvitamin D-3 were confirmed by HPLC and gas chromatography retention time and mass spectroscopy. In characterized human liver microsomes, 24-hydroxylation of 1alphaOHD(2) by CYP3A4 correlated significantly with 6beta-hydroxylation of testosterone, a marker of CYP3A4 activity. 24-Hydroxylase activity in recombinant CYP3A4 and pooled human liver microsomes showed dose-dependent inhibition by ketoconazole, troleandomycin, alpha-naphthoflavone, and isoniazid, known inhibitors of CYP3A4. Rates of 24- and 25-hydroxylation of 1alphaOHD(2) and 1alphaOHD(3) were determined in recombinant wild-type CYP3A4 and site-directed mutants and naturally occurring variants expressed in Escherichia coli. Substitution of residues showed the most prominent alterations of function at residues 119, 120,301, 305, and 479. Thus, CYP3A4 is both a 24- and 25-hydroxylase for vitamin D-2, 1alphaOHD(2), and 1alphaOHD(3).
引用
收藏
页码:1210 / 1219
页数:10
相关论文
共 42 条
  • [1] Quantification of multiple human cytochrome P450 mRNA molecules using competitive reverse transcriptase-PCR
    Andersen, MR
    Farin, FM
    Omiecinski, CJ
    [J]. DNA AND CELL BIOLOGY, 1998, 17 (03) : 231 - 238
  • [2] BELL NH, 2001, PRINCIPLES PRACTICE, P615
  • [3] Therapeutic uses of vitamin D analogues
    Brown, AJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (05) : S3 - S19
  • [4] A POSSIBLE GENETIC-DEFECT IN 25-HYDROXYLATION AS A CAUSE OF RICKETS
    CASELLA, SJ
    REINER, BJ
    CHEN, TC
    HOLICK, MF
    HARRISON, HE
    [J]. JOURNAL OF PEDIATRICS, 1994, 124 (06) : 929 - 932
  • [5] Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
    Cheng, JB
    Levine, MA
    Bell, NH
    Mangelsdorf, DJ
    Russell, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (20) : 7711 - 7715
  • [6] De-orphanization of cytochrome P450 2R1 - A microsomal vitamin D 25-hydroxylase
    Cheng, JB
    Motola, DL
    Mangelsdorf, DJ
    Russell, DW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) : 38084 - 38093
  • [7] Cytochrome P450 3A - Ontogeny and drug disposition
    de Wildt, SN
    Kearns, GL
    Leeder, JS
    van den Anker, JN
    [J]. CLINICAL PHARMACOKINETICS, 1999, 37 (06) : 485 - 505
  • [8] Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: Potent inhibition of CYP2C19 and CYP3A
    Desta, Z
    Soukhova, NV
    Flockhart, DA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 382 - 392
  • [9] Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity
    Domanski, TL
    He, YA
    Khan, KK
    Roussel, F
    Wang, QM
    Halpert, JR
    [J]. BIOCHEMISTRY, 2001, 40 (34) : 10150 - 10160
  • [10] EDWARDS RJ, 1998, BIOCHEM PHARMACOL, V56, P177